Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to ...
Jul 13, 2011
0
0
(Medical Xpress) -- An ongoing study led by a University of Pittsburgh researcher has established the first scientifically-based dosing guidelines for a more than 50-year-old drug that has re-emerged as the best, and often ...
Jul 4, 2011
0
0
Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers.
Jun 2, 2011
0
0
A new vaginal microbicide gel and drug formulation looks promising for empowering women in developing countries to protect themselves from HIV during intercourse, without having to inform their partners, according to research ...
Apr 20, 2011
0
0
In the war on cancer, powerful chemotherapy agents are increasingly packaged with immunotherapy that primes a patient's immune system to better battle the disease.
Apr 17, 2017
0
2
Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.
Sep 19, 2016
0
3
Is the end of HIV near? Findings published this week in Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs shows extreme promise in stopping the spread ...
Apr 28, 2015
1
679
Researchers have synthesized a molecule that can silence the gene responsible for severe antibiotic resistance in some bacteria. The research, presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy ...
Sep 8, 2014
0
0
Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, ...
Jul 15, 2013
0
0
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, ...
Jun 12, 2013
0
0
